期刊文献+

CICARE模式联合微信对门诊患者生物制剂注射依从性的影响

下载PDF
导出
摘要 目的探讨CICARE沟通模式联合微信对门诊患者生物制剂注射依从性的效果。方法选择2018年2—4月在我科门诊注射生物制剂医嘱频率相同的70例患者,分为两组,每组35例。实验组在患者首次来院注射生物制剂时,使用CICARE沟通模式进行注射相关注意事项、疾病相关健康知识指导,并由专业护理小组成员利用微信定期对患者进行相关指导、答疑及注射时间提醒,对照组仅在来院注射时行常规药物注射相关注意事项、疾病相关健康知识指导,告知下次注射时间。比较两组1个月后、3个月后、6个月后定期按时来院注射生物制剂依从性。结果实验组1个月后、3个月后、6个月后定期按时来院注射生物制剂依从性均明显高于对照组,差异有统计学意义(P<0.05)。结论运用CICARE沟通模式联合微信能提高门诊患者生物制剂注射依从性,提高药物有效性,值得推广。
作者 何玉红
出处 《当代护士(下旬刊)》 2020年第6期114-116,共3页 Modern Nurse
  • 相关文献

参考文献10

二级参考文献98

  • 1唐福林.应规范类风湿关节炎的诊断与治疗[J].中华医学杂志,2004,84(12):971-973. 被引量:6
  • 2何斌.访斯坦福医院有感-CICARE模式介绍[EB/OL].[2011-11-16].http://www.e5413.com/NewsMessage-9048.aspx.
  • 3古洁诺,陶怡.1临床风湿病学教程[M].北京:人民卫生出版社,2009:319.
  • 4Schabert VF, Watson C, Joseph GJ, et al. Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population[J]. J Manag Care Pharm, 2013, 19(8): 621-630.
  • 5Xu C, Wang X, Mu R, et al. Societal costs of rheumatoid arthritis in China: a hospital-based cross-sectional study[J]. Arthritis Care Res (Hoboken), 2014, 66(4): 523-531.
  • 6Van der Heijde D, Klareskog L, Landewe R, et al. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis[J]. Arthritis Rheum, 2007, 56 ( 12): 3928- 3939.
  • 7Emery P, Breedveld F, van der Heijde D, et al. Two-year clinical and radiographic results with combination etanercept- methotrexate therapy versus monotherapy in early rheumatoidarthritis: a two-year, double-blind, randomized study[J]. Arthritis Rheum, 2010, 62(3): 674-682.
  • 8Braun J, van der Horst-Bruinsma IE, Huang F, et al. Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial[J]. Arthritis Rheum, 2011, 63(6): 1543-1551.
  • 9Hetland ML, Christensen IJ, Tarp U, et al. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etan- ercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry[J]. Arthritis Rheum, 2010, 62( 1 ) : 22-32.
  • 10Blum MA, Koo D, Doshi JA. Measurement and rates of per- sistence with and adherence to biologics for rheumatoid arthritis: a systematic review[J]. Clin Ther, 2011, 33(7): 901-913.

共引文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部